American Healthcare REIT, Inc 8-K/A, filed Feb 12, 2021
American Healthcare REIT, Inc. (AHR)
8-K/A
2021-02-12
For: 2021-02-01
View Original
Added on
April 10, 2026
About this 8-K/A
American Healthcare REIT, Inc filed this 8-K/A on February 12, 2021, reporting on events of February 1, 2021.
Items reported
- Item 8.01: Other events
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): February 1, 2021
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
| (Address of principal executive offices) | (Zip Code) | |||||||||||||
Registrant’s telephone number, including area code: (949 ) 270-9200
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
| None | None | None | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒
EXPLANATORY NOTE
We previously filed a Current Report on Form 8-K, or the Form 8-K, on February 3, 2021, to report the authorization and declaration of distributions by our board of directors. We are filing this Current Report on Form 8-K/A, Amendment No. 1, for the sole purpose of adding Inline eXtensible Business Reporting Language, or XBRL, data tagging to the cover page in accordance with Rule 406 of Regulation S-T, which XBRL data tagging was inadvertently omitted from the Form 8-K. No other changes have been made to the Form 8-K.
Item 8.01 Other Events.
Our board of directors authorized a daily distribution to our Class T and Class I stockholders of record as of the close of business on each day of the period commencing on February 1, 2021 and ending on February 28, 2021. The daily distributions will be calculated based on 365 days in the calendar year and will be equal to $0.001095890 per share of our common stock, which is equal to an annualized distribution of $0.40 per share. The distributions will be aggregated and paid in cash or shares of our common stock pursuant to our distribution reinvestment plan on a monthly basis in March 2021, only from legally available funds.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Griffin-American Healthcare REIT IV, Inc. | ||||||||
| February 12, 2021 | ||||||||
By:/s/ Jeffrey T. Hanson | ||||||||
Name: Jeffrey T. Hanson | ||||||||
Title: Chief Executive Officer | ||||||||